期刊文献+

hBSP与GFP非融合表达载体的构建及乳腺癌细胞转染条件优化 被引量:2

Construction of hBSP Eukaryon Expression Vector Carrying GFP and Optimization of Transfection Conditions for Breast Cancer Cells
下载PDF
导出
摘要 为进一步研究骨唾液蛋白(BSP)在乳腺癌细胞骨转移的整个过程中的作用,首先要建立稳定高效表达BSP的乳腺癌细胞系.文中首先从构建好的pB-hBSP载体中亚克隆hbsp基因,构建重组质粒pIRES2-hBSP-EGFP,然后利用脂质体介导转染特异性骨转移的乳腺癌细胞MDA-MB-231BO,优化一系列转染条件以提高转染效率,再利用G418和流式细胞仪筛选获得稳定转染细胞.结果发现:在96孔板中,细胞融合度达到90%;用1μg脂质体介导280 ng重组质粒转染10 h,转染效率最高可达(19.70±1.10)%. In order to study the role of bone sialoprotein (BSP) in the metastasis of breast cancer cells to bones, a breast cancer cell line stably expressing BSP should be established. In this paper, hbsp gene was subcloned from constructed pB-hBSP vector and was then inserted into pIRES2-EGFP, thus constructing the recombinant plasmid pIRES2-hBSP-EGFP. Moreover, by the transfection of breast cancer cell MDA-MB-231BO mediated by Lipofectamine^TM 2000, the corresponding transfection conditions were optimized to improve the transfection efficiency. Stably transfected breast cancer cells were finally obtained by the selection via G418 and flow cytometry. It is found that, in a 96-well cell culture plate, the cell growth confluence is up to 90%, and that when 1μg of Lipofectamine^TM 2000 is used to mediate 280ng of recombinant plasmid transfecting breast cancer cells for 10h, the tranfection efficiency is up to (19.70 ±1.10)%.
出处 《华南理工大学学报(自然科学版)》 EI CAS CSCD 北大核心 2005年第11期46-50,共5页 Journal of South China University of Technology(Natural Science Edition)
基金 广东省自然科学基金资助项目(04003534) 广东省医学科研基金资助项目(A2002536)
关键词 骨唾液蛋白 荧光蛋白 重组表达载体 乳腺癌细胞 转染 优化 bone sialoprotein fluorescent protein recombinant expression vector breast cancer cell transfection optimization
  • 相关文献

参考文献11

  • 1Yoneda T. Cellular and mlecular mchanisms of beast and postate cncer mtastasis to bone [J]. European Journal of Cancer, 1998,34 (2): 240 - 245.
  • 2Mundy G R. Metastasis to bone: Causes, consequences and therapeutic opportunities [ J]. Nat Rev Cancer,2002,2(8) :584 -593.
  • 3Toshiyuki Yoneda. Cellular and molecular basis of preferential metastasis of breast cancer to bone [ J ]. J Orthop Sci ,2000 ( 5 ) :75 - 81.
  • 4Bellahcene A, Merville M P, Castronovo V. Expression of bone sialoprotein, a bone matrix protein,in human breast cancer [ J]. Cancer Research 1994, 54 ( 11 ): 2 823 -2 826.
  • 5Seibel M J, Woitge H W, Pecherstorfer M, et al. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease [ J ]. J Clin Endocrinol Metab, 1996,81:3289 - 3296.
  • 6Diel Ingo J,Solomayer Erich-franz,Seibel Markus J,et al.Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis [J]. Clinic Cancer Research,1999(5) :3914 -3919.
  • 7Tharwat Ibrahim, Lona Leong, OttoSanchez-Sweatman, et al. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases [ J ]. Clinical & Experimental Metastasis,2000,18:253 - 260.
  • 8王捷,董燕,张宏斌,武婕,郑文岭.人骨唾液蛋白基因的克隆及其在毕赤酵母中的表达[J].中国生物化学与分子生物学报,2004,20(3):325-329. 被引量:13
  • 9吴虹,陈光明,宗敏华,杨汝德.含CpG motifs的乙肝表面抗原载体的构建及表达(英文)[J].华南理工大学学报(自然科学版),2002,30(4):19-22. 被引量:1
  • 10蒋欣泉,张志愿,曹俊,陈传俊,王明国,周晓健,陈万涛.绿色荧光蛋白基因转染骨髓基质干细胞的瞬时表达检测[J].华西口腔医学杂志,2003,21(2):89-91. 被引量:6

二级参考文献19

  • 1[1]Krieg A M, Yi A K, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation [J]. Nature, 1995,374(6522):546-549.
  • 2[2]Klinman D M, Yi A K, Beaucage S L, et al. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interlerkin 12, and interferon γ [J]. Proc Natl Acad Sci USA, 1996,93(7):2 879-2 883.
  • 3[3]Lowrie D B, Whalen R G. DNA vaccine methods and protocols [M]. New Jersey: Humana Press, Totowa, 1999. 169-172.
  • 4[4]Sambrook J, Fritsch E F, Maniatis T. Molecular cloning: a laboratory manual [M]. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989.
  • 5[1]Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science,1997,276(5309):71-74
  • 6[2]Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression. Science,1994,263(5148):802-805
  • 7[3]Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene,1996,173(1):33-38
  • 8[4]Evans CH, Robbins PD. Genetically augmented tissue engineering of the musculoskeletal system. Clin Orthop,1999,367(suppl):410-418
  • 9[5]Moutsatsos IK, Turgeman G, Zhou S,et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther, 2001,3(4):449-461
  • 10[7]Trimble R B, Atkinson P H, Tschopp J F, Townsend R R, Maley F.Structure of oligosaccharides on Saccharomyces SUC2 invertase secreted by the methylotrophic yeast Pichia pastoris. J Biol Chem, 1991, 266(34): 22807 ~ 22817

共引文献21

同被引文献11

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部